Genesis Therapeutics

Genesis Therapeutics develops advanced molecular AI platforms tailored for drug discovery, unifying cutting-edge foundation models with molecular physics to accelerate and optimize the drug development process. Their flagship platform, GEMS, acts as an AI operating system for molecular design and is utilized by their internal R&D teams as well as large pharmaceutical partners to tackle challenging drug targets. This tool is intended for researchers, scientists, and pharma companies seeking to leverage AI-driven molecular design and discovery workflows.